ARCHIVES

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004

GM Corp, to Reimburse Marrow Transplants for Breast Cancer

March 15, 1996

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

NCI, MABCO Publish Clinical Trials Web Site

September 6, 1996

HHA “Investigative Memorandum” Revives Controversy Over AIDS Virus, Royalties

July 1, 1994

NCCS Networker Volume 2 Issue 4, Fall 1988

September 13, 1988